|
|
| About the manufacturer of
Metronidazole – Flagyl |
Pfizer is an American pharmaceutical company responsible for the
development of Metronidazole – Flagyl. In 2006, the group is
the leader in its sector globally with a turnover amounting to 48371
billion dollars (2006), a market capitalization of 219 billion, and
staffing of employees 100000 the world. The group has made an
investment in 2006 to 7599 billion dollars in research and
development and a profit of 19.3 billion, or 40% of its turnover, an
increase of 130% compared to 2005, from the sale of its products
division of public health to Johnson & Johnson. Pfizer is listed on
the NYSE and is part of the DJIA (Dow Jones Industrial Average).
In India Metronidazole – Flagyl is manufactured by many
companies out of which Retailpharma and Richierich Exports are two
of them. Pfizer was founded in 1849 by Charles Pfizer and Charles
Erhart. After developed in the United States, the company has
expanded from its 1951 activities to the world and the success of
Metronidazole – Flagyl speaks for itself.
Pfizer has a tetrahedral organization composed of four core business
units are: to the medical centre for human (44.28 billion dollars in
2005); products advice (3.87 billion dollars in 2005); veterinary
care (2.2 billion dollars in 2005) and one pole comprising various
activities especially in finance and law in the majority. On June
26, 2006 Pfizer announced the sale of a portion of its products to
laboratories Johnson & Johnson for the sum of 16.6 billion dollars,
consisting of, among other products such as Nicorette and Sudafed.
Since 2000, the company's growth has been, like many other
laboratories in the sector, through acquisitions; Warner-Lambert
(2000) and Pharmacia (2003).
|
|
